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Abstract
Background: bFGF is an important growth factor for glioma cell proliferation and invasion, while connexin 43 is
implicated in the suppression of glioma growth. Correspondingly, gliomas have been shown to have reduced, or
compromised, connexin 43 expression.
Methods: In this study, a bFGF-targeted siRNA was delivered to the glioma cell line, U251, using adenovirus (Ad-
bFGF-siRNA) and the expression of connexin 43 and its phosphorylation state were evaluated. U251 cells were
infected with Ad-bFGF-siRNA (100, 50, or 25 MOI), and infection with adenovirus expressing green fluorescent
protein (Ad-GFP) at 100 MOI served as a control. Western blotting and immunofluorescence were used to detect
the expression levels, phosphorylation, and localization of connexin 43 in U251 cells infected, and not infected,
with Ad-bFGF-siRNA.
Results: Significantly higher levels of connexin 43 were detected in U251 cells infected with Ad-bFGF-siRNA at 100
and 50 MOI than in cells infected with Ad-GFP, and the same amount of connexin 43 was detected in Ad-GFP-
infected and uninfected U251 cells. Connexin 43 phosphorylation did not differ between Ad-bFGF-siRNA-infected
and uninfected U251 cells. However, the ratio of phosphorylated to unphosphorylated connexin 43 in Ad-bFGF-
siRNA cells was lower, and connexin 43 was predominantly localized to the cytoplasm. Using a scrape loading dye
transfer assay, more Lucifer Yellow was transferred to neighboring cells in the Ad-bFGF-siRNA treated group than
in the control group.
Conclusion: To our knowledge, this is the first description of a role for connexin 43 in the inhibition of U251
growth using Ad-bFGF-siRNA.
Background
Basic fibroblast growth factor (bFGF) is a heparin-bind-
ing growth factor that is secreted as a pleiotropic pro-
tein and can act on various cell types, including tumor
cells. bFGF is hypothesized to have a critical role in the
development of the nervous system [1], and for gliomas,
the level of bFGF present has been shown to correlate
with tumor grade and clinical outcome [2], bFGF has
also been shown to be up-regulated in transformed glial
cells and to be overexpressed in malignant gliomas [3].
bFGF exerts its cellular functions through the binding of
four FGF receptors (FGFRs), all of which are receptor
tyrosine kinases (RTKs). The binding of bFGF by FGFRs
recruits and activates several signaling pathways [4].
Accordingly, down-regulation of bFGF using antibodies
or antisense sequences has been shown to inhibit tumor
cell tumorigenicity and metastasis [3,5,6]. A study by De
Vuyst et al. also demonstrated a role for bFGF in the
inhibition of gap junction (GJ) communication in the
glioma cell line, C6, following exogenous expression of
connexin 43 [7].
Connexin 43 (Cx43) is the predominant component of
GJs which are composed of six connexin proteins and
are differentially expressed in various cell types [8]. Sev-
eral studies have demonstrated that Cx43 is one of the
major GJ proteins expressed by astrocytes and glial cells
[9], and in high-grade human gliomas, its expression is
significantly reduced. Decreased expression of Cx43
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of the central nervous system, can also affect GJ inter-
cellular communication (GJIC) [10,11]. Restoration of
GJIC by exogenous expression of Cx43 has reversed the
transformed phenotype of certain tumor cells, including
high-grade human gliomas [12,13]. In addition, suscept-
ibility of the transfected glioma cells to apoptosis was
enhanced in response to chemotherapeutic agents [14].
While it has been found that expression of Cx43 is
inversely related to glioma cell proliferation and tumor
grade [12,15,16], the specific regulatory mechanisms
involving Cx43 in gliomas remains unclear.
In the present study, down-regulation of bFGF expres-
sion by a siRNA specifically targeted to bFGF is shown
to significantly increase the expression of Cx43 without
effecting the phosphorylation of Cx43 at S368 in the
glioma cell line, U251.
Methods
Adenoviral vector construction
From four siRNA sequences that were designed for tar-
geting bFGF, an optimalt a r g e ts e q u e n c e( 5 ’-
CGAACTGGGCAGTATAAACTT-3’) was selected [17]
and cloned into the plasmid vector, pGenesil-1. The
siRNA expression cassette was subsequently excised
from pGenesil-1 using EcoRIa n dH i n d I I Ia n dl i g a t e d
into the linearized adenoviral shuttle vector, pGStrack-
CMV. pGStrack-CMV-bFGF-siRNA was then co-trans-
fected with the pAd vector backbone into DH5a bac-
teria for the recombinant generation of Ad-bFGF-
siRNA, which was further amplified in HEK293 cells.
Viral particles were purified using cesium chloride den-
sity gradient centrifugation.
Cell culture and adenovirus infection
The human glioma cell line, U251, was maintained in
Dulbcco’s modified Eagle medium (DMEM) supplemen-
ted with 10% heat inactivated fetal bovine serum (FBS),
100 U/ml of penicillin, and 100 μg/ml of streptomycin
in a humidified atmosphere containing 5% CO2 at 37°C.
All media and serum were purchased from Gibcol.
U251 cells (1 × 10
5) in serum-free DMEM were
infected with Ad-bFGF-siRNA at 100, 50, and 25 MOI
(MOI is calculate as PFU/cell numbers) in a humidified
atmosphere containing 5% CO2 at 37°C. Infection with
Ad-GFP at 100 MOI served as a control. Virus-contain-
ing medium was removed 8 h later and replaced with
fresh DMEM medium containing 10% FBS. Cells were
incubated for another 72 h, then mRNA or protein was
extracted.
MTT assay for cell proliferation
Cell proliferation was measured using MTT assay. 5 ×
10
3 cells/well were seeded into 96 wells plate. After the
adhesion of the cells, they were infected with Ad-bFGF-
siRNA, meanwhile untreated cells and cells infected
with Ad-GFP served as control and mock control. Dur-
ing consecutive seven days, 20 μl MTT solution (5 mg/
ml) in PBS was added to each well for 4 h. After the
culture medium was drained out, 150 μlo fD M S Ow a s
added into each well. Absorbance of each well was mea-
sured on a microplate reader. Three duplicate wells
were set up for each group.
RT-PCR
Total RNA was extracted from cultured cells using TRi-
zol reagents (Invitrogen, Carlsbad, CA, USA) according
to the manufacturer’s directions. First-strand cDNA was
synthesized from total RNA(1 μg) using AMV reverse
transcriptase (TaKaRa) with oligo(dT) primer at 42°C
for 1 h in a 25 μlv o l u m e .R Tp r o d u c t( 2μl) with
cDNAs was mixed with bFGF or b-actin specific primers
in a PCR buffer containing 2.5 mM dNTP, 2.5 mM
MgCl2 and 1 U Taq polymerase (TaKaRa). PCR amplifi-
cation was performed over 31 cycles (45 sec at 94°C, 60
sec at 60°C, and 45 sec at 72°C) to amplify bFGF, and
over 25 cycles (30 sec at 94°C, 30 sec at 57°C, and 90
sec at 72°C) to amplify b-actin. Primers used for ampli-
fying bFGF included: forward-5’-CACCATGGCAGCC
GGCAGCATCA-3’ and reverse-5’-TCAGCTCTTAGC
AGACATTGG-3’. Primers used to amplify b-actin
included: forward-5’-CCTCGCCTTTGCCGATC-3’ and
reverse-5’-GGATCTTCATGAGGTAGTCAGTC-3’.
Amplified DNA fragments were separated in 2% agarose
gels and visualized using ethidium bromide staining.
Western blotting
Western blot analysis was performed on whole cell
extracts obtained by direct dissolution of cells in culture
flasks using a whole cell protein extract reagent accord-
ing to the manufacturer’s directions (PIERCE). Protein
concentrations were determined using a bicinchoninic
acid (BCA) protein assay kit with bovine serum albumin
as a standard. Proteins (40 μg/lane) were separated on
12% SDS-PAGE gels and transferred onto polyvinylidene
difluoride (PVDF) membranes. Membranes were
blocked with 3% fat-free milk in PBST (0.2% Tween-20
in PBS, pH 7.6) then incubated with primary antibody
for 18-24 h at 4°C. Membranes were subsequently incu-
bated with secondary antibodies conjugated to horserad-
ish peroxidase (1:5000) for 1 h at RT. Bound antibody
was visualized using an Enhanced Chemiluminescence
(ECL) western blot detection kit (Amersham Pharmacia
Biotech). Primary antibodies used included: anti-bFGF
(rabbit polyclonal, 1:1000, Santa Cruz), anti-Cx43 (rabbit
polyclonal, 1:1000, Cell Signaling), anti-pCx43 for S368
(rabbit polyclonal, 1:1000, Cell Signaling), and anti-b-
actin (mouse monoclonal, 1:1000, Santa Cruz).
Immunofluorescence
U251 cells grown on cover slips were fixed with 4% par-
aformaldehyde for 15 min and permeabilized with 0.5%
Triton X-100/PBS (Sigma-Aldrich) for 20 min. Cells
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bovine serum albumin (BSA) for 30 min prior to incu-
bating the cells with primary antibodies recognizing
Cx43 or p-Cx43 (S368) for 1 h in a humidified chamber.
After several PBS washes, cells were incubated with tet-
raethyl rhodamine isothiocyanate(TRITC)-conjugated
secondary antibodies for 1 h. After washing with PBS,
cells were stained with Hoechst 33258 (Sigma-Aldrich)
for 15 min and immunofluorescence was detected using
a fluorescence microscope (Olympus).
Scrape loading and dye transfer (SL/DT)
Levels of GJIC in control and treated U251 cells were
determined using the scrape loading and dye transfer
(SL/DT) technique with the fluorescent dye, Lucifer Yel-
low (LY), as a readout (Sigma). Briefly, U251 cells were
seeded in 6-well plates and grown to confluency. After
rinsing with PBS, cells were incubated with 0.05% (w/v)
Lucifer Yellow in PBS. Scrape loading was performed
using a surgical scalpel to draw several clear straight
lines on the cell monolayer. After 5 min, the Lucifer
Yellow solution was removed, cells were washed 4 times
with PBS, and transfer of Lucifer Yellow was detected
using an inverted fluorescence microscope.
Statistical Analysis
All data were analyzed using SPSS 13.0 software. Signifi-
cant differences were determined using either one-way
analysis of variance (ANOVA) or a two-tailed Student t-
test. A p-value < 0.05 was considered significant.
Results
Down-regulation of bFGF mRNA and protein in U251 cells
using bFGF-targeted siRNA
To examine changes in bFGF gene expression induced
by adenoviral infection of bFGF-targeted siRNA, RT-
PCR and western blot were performed. Both mRNA and
protein levels of bFGF in Ad-bFGF-siRNA-infected
U251 cells were dramatically reduced compared to
bFGF levels in U251 infected with Ad-GFP or unin-
fected U251 (Fig. 1A, B). These results indicate that
bFGF siRNA delivered by adenoviral infection can speci-
fically suppress the expression of bFGF in U251 cells.
Meanwhile, U251 cells, which were inhibited expression
of bFGF using Ad-bFGF-siRNA, showed decrease of
proliferation and survival rate compared to untread
U251 cells and Ad-GFP treatment detected by MTT
assay(Fig. 2A, B).
The effect of bFGF-targeted siRNA on connexin 43 and
phosphorylation of connexin 43 at PKC target site S368
in U251 cells
Expression of Cx43 and phosphorylation of Cx43 at
PKC target site S368 was detected in both bFGF-inhib-
ited and uninhibited U251 cells using western blotting.
In addition, the subcellular distribution of them in U251
cells was examined using indirect immunofluorescence.
Western blotting revealed that inhibition of bFGF corre-
lated with significantly higher levels of an immunoreac-
tive 43 kDa band detected by a polyclonal Cx43
antibody relative to untreated U251 cells (Fig. 3A, B).
While, down-regulation of bFGF did not affect phos-
phorylation of Cx43 at S368(Fig. 3A, C). Immunofluor-
escence studies identified Cx43 and p-Cx43 to be
predominantly localized to the cytoplasm (Fig. 4A, B).
Infection with Ad-bFGF-siRNA improves intercellular
communication
Scrape loading and dye transfer (SL/DT) assays were
used to evaluate the permeability of GJs in U251 cells
infected with Ad-bFGF-siRNA. Detection of the fluores-
cent dye, Lucifer Yellow (LY), showed a higher number
of Ad-bFGF-siRNA-infected cells exhibited fluorescence
than untreated U251 cells (Fig. 5). These results indicate
that down-regulation of bFGF increased the GJIC
between U251 cells.
Discussion
The autocrine and paracrine signaling of bFGF makes it
one of the most potent mitogenic factors for glial cell
growth and differentiation. High levels of bFGF expres-
sion have also been associated with malignant grades of
glioma, and in neoplastic astrocytes, bFGF stimulates
the proliferation of astrocytoma cells. Conversely, inhibi-
tion of bFGF expression, or receptor binding of bFGF,
has been demonstrated to inhibit glioma proliferation
both in vitro and in vivo [18]. In the present study,
infection with Ad-bFGF-siRNA down-regulated expres-
sion of bFGF in U251 cells, inhibited cell proliferation,
and increased expression of Cx43. Huang have reported
that Cx43 may suppress glioma proliferation by dowre-
gulation of monocyte chemotactic protein 1(MCP-1)
[19], the inhibitory effect of bFGF siRNA on U251 cell
proliferation is at least partially due to the increased
expression of Cx43, which may affect expression of
other growth factors, such as down regulating MCP-1.
However the correlation between downregulation of
bFGF and inducion of Cx43 is still unclear, Ueki’study
may provided some implicant, Ueki demonstrated in
cortical astrocytes that epidermal growth factor (EGF)
results in a decrease in the expression of Cx43 mRNA
and protein and the decrease is associated with the
receptor tyrosine kinase pathway, meanwhile the MEK
inhibitor prevents EGF-stimulated down-regulation of
Cx43 expression[20].
Immunofluorecence studies further demonstrated that
increased expression of Cx43 localized primarily to the
cytoplasm, with fewer molecules localizing to the peri-
nucleus and sporadic plaques detected at the plasma
membrane. In addition, dye transfer assays demon-
strated that intercellular communication was improved
for U251 cells infected with Ad-bFGF-siRNA. Consistent
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Page 3 of 7Figure 1 Infection with Ad-bFGF-siRNA decreased the expression of bFGF mRNA and protein in U251 cells in a dose-dependent
manner. The level of bFGF mRNA (A) and protein (B) in control, Ad-GFP, and Ad-bFGF-siRNA-infected U251 cells as measured by RT-PCR and
western blot. The upper panels include representative RT-PCR and western blot results, while the lower panels provide the relative band density
ratios for bFGF mRNA and protein relative to b-actin (mean ± SD, n = 3) (*p < 0.05 vs. control).
Figure 2 Infection with Ad-bFGF-siRNA inhibited the proliferation of U251 cells. Decrease of proliferation (A) and survival rate (B)i nA d -
bFGF-siRNA treated U251 cells compared to untread U251 cells and Ad-GFP treated U251 cells. (mean ± SD, n = 3) (*p < 0.05 vs. control)
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that although localization of Cx43 was predominant at
cytoplasm, the functions of GJIC mediated by Cx43
were normal.
Lack of Cx43 expression and aberrant localization of
Cx43 have been associated with a lack of GJIC between
tumor cells [23]. While gene mutations may play a role
in deficient Cx43 expression, the precise mechanisms
involved in decreased expression of Cx43 in tumor cells
is still unclear. An increasing number of studies have
shown that Cx43 can abnormally localize and accumu-
late in the cytoplasm in some cancer cell lines, including
glioma cell lines. However, nuclear localization of con-
nexin 43 has been reported in both src and neu onco-
gene-transformed rat liver epithelial cells [23]. Aberrant
localization of Cx43 may also be associated with intact
function of cytoskeletal elements [24].
Several studies have reported a role for Cx43 in both
physiological and pathological conditions, although with
contrasting results [25-27]. There are two mechanisms
that have been postulated to explain the observed dis-
crepancies. For example, Cx43 may directly mediate
intercellular communication to permit the transport of
factors that inhibit or enhance cell growth, or alterna-
tively, Cx43 may affect GJs directly [28,29]. Based on
studies in a rat glioma cell line, regulation of glioma
growth is proposed to be more dependent on the beha-
vior of connexins than the activity of GJIC [30]. There-
fore, it is possible that Cx43 may effect tumor growth
independently of GJ formation. Despite these insights,
further studies are necessary to define the precise role
of Cx43 in glioma cell communication and growth.
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Figure 3 Ad-bFGF-siRNA in U251 cells increases connexin 43 protein levels and no affect the level of p-connexin 43 at S368 site. A)
Expression of connexin 43 and p-connexin 43 at S368 site U251 cells infected with Ad-bFGF-siRNA and untreated U251 cells. A representative
western blot is shown. B) Relative density values of Cx43 compared to b-actin from western blot analysis are provided. C) Relative density values
of p-Cx43 compared to Cx43 from western blot analysis are provided. (mean ± SD, n = 3) (*p < 0.05 vs. control).
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Page 5 of 7Figure 4 Subcellular localization of Cx43 and p-Cx43 (S368) in Ad-bFGF-siRNA infected U251 cells. A) Subcellular localization of Cx43 in
U251 cells stained with anti-Cx43 antibody and with Hoechst 33258 staining to identify nuclei. B) Subcellular localization of p-Cx43(S368) in
U251 cells stained with an anti-p-Cx43 antibody and Hoechst 33258 staining to identify nuclei.
Figure 5 Ad-bFGF-siRNA improves GJIC between U251 cells. GJIC was assessed in U251 cells infected with Ad-bFGF-siRNA (100 MOI) for 48
h compared to untreated U251 cells using scrape loading dye transfer assays. A) In untreated cells, Lucifer Yellow was restricted to the cells at
the border of the scraped line with only minimal transfer of Lucifer Yellow to neighboring cells. B) In Ad-bFGF-siRNA U251 cells, an increase in
the transfer of Lucifer Yellow between cells was detected.
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